Non-clinical safety assessment of homeopathic medicinal products: criteria for establishing a first safe dilution

被引：0
|
作者：
Buchholzer, M. -L. [1 ]
Werner, C. [1 ]
Knoess, W. [1 ]
机构：
[1] BfArM Bundesinst Arzneimittel & Med Prod Zulassun, D-53175 Bonn, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2012年 / 385卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
066
引用
收藏
页码：17 / 17
页数：1
相关论文
共 48 条
  • [1] Safety pharmacology for the non-clinical assessment of medicinal products
    MacKenzie, I
    [J]. DRUG DISCOVERY TODAY, 2002, 7 (04) : 232 - 234
  • [2] Non-clinical vaccine safety assessment
    Verdier, F
    [J]. TOXICOLOGY, 2002, 174 (01) : 37 - 43
  • [3] Imaging modalities and their usefulness in non-clinical safety assessment
    Le Pape, A.
    Reveillon, G.
    Lerondel, S.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S24 - S24
  • [4] Liver imaging applications in non-clinical safety assessment
    Hockings, P.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S24 - S24
  • [5] Safety pharmacology in the non clinical assessment of new medicinal products: place, interest and difficulties
    Claude, J. R.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 2 - 2
  • [6] Non-clinical assessment design of autologous chondrocyte implantation products
    Ikawa, Taisuke
    Yano, Kazuo
    Watanabe, Natsumi
    Masamune, Ken
    Yamato, Masayuki
    [J]. REGENERATIVE THERAPY, 2015, 1 : 98 - 108
  • [7] Non-clinical Safety Assessment of Angiotensin 1-7
    Thun, S.
    Petersen, K. U.
    Christoph, T.
    Schmitz, U.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S79 - S79
  • [8] Variability of non-clinical behavioral CNS safety assessment: An intercompany comparison
    Himmel, H. M.
    Delaunois, A.
    Deurinck, M.
    Dinklo, T.
    Faelker, Eriksson T. M.
    Habermann, C.
    Heers, C.
    Hempel, K.
    Lorenz, H.
    Rosch, A.
    Schauerte, H.
    Teuns, G.
    Traebert, M.
    van Amsterdam, C.
    van der Linde, H.
    [J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2019, 99
  • [9] Non-clinical safety assessment of gadoterate meglumine (Dotarem®) in neonatal and juvenile rats
    Giorgi, Herve
    Ammerman, Jennifer
    Briffaux, Jean-Paul
    Fretellier, Nathalie
    Corot, Claire
    Bourrinet, Philippe
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2015, 73 (03) : 960 - 970
  • [10] Molecular imaging in non-clinical species and humans - Options and reality in safety assessment
    Bergstroem, M.
    [J]. TOXICOLOGY LETTERS, 2011, 205 : S25 - S25
12345